Warning relating to veterinary use of Hibiwash 4% w/v Cutaneous Solution Clorhexidine gluconate 500 ml

26.3.2026

  | Her Majesty's Revenue and Customs

 Recall alert for specific batches of Hibiwash due to potential risk of microbial contamination with Burkholderia cepacia complex (BCC). 


We would like to make veterinary surgeons aware that the MHRA issued a recall regarding specific batches of Hibiwash Chlorhexidine gluconate 4% 500ml on 23 March 2026 due to a potential risk of microbial contamination with Burkholderia cepacia complex (BCC).

This follows the detection of BCC in the purified water system during routine microbiological testing at their manufacturing facility.

Therefore, the VMD would like to bring the following information, issued by MHRA, to the attention of the RCVS and veterinary practices.

The investigation is ongoing, and to date no Hibiwash products have been found to be contaminated. However, batches potentially at risk of contamination are being recalled as a precautionary measure to mitigate any risks to public health.

This issue impacts the UK. Batches manufactured for France and the Netherlands have been quarantined. Other batches may be impacted if manufactured at Purna manufacturing site in Belgium during the period from January to March 2026.

Affected Lot Batch Numbers:



Batch number
Expiry Date




5156042
11/2028


5156043
11/2028


5156093
11/2028



MHRA has provided further details and precautionary advice for healthcare professionals, retailers, patients and customers:

Class 2 Medicines Recall: Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml, EL(26)A/15 - GOV.UK

https://www.gov.uk/government/news/warning-relating-to-veterinary-use-of-hibiwash-4-wv-cutaneous-solution-clorhexidine-gluconate-500-ml